Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Sales | 622,243 | 568,082 | 431,911 | 556,165 | 515,874 |
| Cost of Goods | 106,867 | 102,444 | 98,428 | 96,030 | 76,188 |
| Gross Profit | 515,376 | 465,638 | 333,483 | 460,135 | 439,686 |
| Operating Expenses | 397,478 | 373,561 | 396,482 | 382,790 | 370,834 |
| Operating Income | 118,765 | 92,521 | -62,571 | 77,375 | 69,040 |
| Interest Expense | 0 | 0 | 0 | 1,719 | 1,345 |
| Other Income | -489,175 | 36,410 | 139,560 | 0 | 0 |
| Pre-tax Income | -370,410 | 128,931 | 76,989 | 75,656 | 67,695 |
| Income Tax | -156,762 | 33,628 | 34,892 | 32,915 | 29,047 |
| Net Income Continuous | -213,648 | 95,303 | 42,097 | 42,741 | 38,648 |
| Net Income | $-213,648 | $95,303 | $42,097 | $42,741 | $38,648 |
| EPS Basic Total Ops | -0.21 | 0.09 | 0.05 | 0.04 | 0.04 |
| EPS Basic Continuous Ops | -0.21 | 0.09 | 0.05 | 0.04 | 0.04 |
| EPS Diluted Total Ops | -0.21 | 0.09 | 0.04 | 0.04 | 0.04 |
| EPS Diluted Continuous Ops | -0.21 | 0.09 | 0.04 | 0.04 | 0.04 |
| EBITDA(a) | $187,085 | $160,446 | $46,625 | $183,958 | $175,398 |